| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The Lancet Gastroenterology & Hepatology 2 (3), 161-176, 2017 | 2076 | 2017 |
| Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B JP Villeneuve, LD Condreay, B Willems, G Pomier‐Layrargues, ... Hepatology 31 (1), 207-210, 2000 | 810 | 2000 |
| Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants GM Hirschfield, X Liu, C Xu, Y Lu, G Xie, Y Lu, X Gu, EJ Walker, K Jing, ... New England Journal of Medicine 360 (24), 2544-2555, 2009 | 712 | 2009 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 559 | 2014 |
| Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population M Sherman, KM Peltekian, C Lee Hepatology 22 (2), 432-438, 1995 | 542 | 1995 |
| Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ... Nature genetics 42 (8), 658-660, 2010 | 466 | 2010 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 413 | 2014 |
| Sirolimus-tacrolimus combination immunosuppression VC McAlister, Z Gao, K Peltekian, J Domingues, K Mahalati, ... The Lancet 355 (9201), 376-377, 2000 | 404 | 2000 |
| Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events M Laryea, KD Watt, M Molinari, MJ Walsh, VC McAlister, PJ Marotta, ... Liver transplantation 13 (8), 1109-1114, 2007 | 353 | 2007 |
| Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature M Aljiffry, A Abdulelah, M Walsh, K Peltekian, I Alwayn, M Molinari Journal of the American College of Surgeons 208 (1), 134-147, 2009 | 290 | 2009 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 273 | 2014 |
| Burden of disease and cost of chronic hepatitis C infection in Canada. RP Myers, M Krajden, M Bilodeau, K Kaita, P Marotta, K Peltekian, ... Canadian journal of gastroenterology & hepatology 28 (5), 243-250, 2014 | 204 | 2014 |
| Acute liver failure induced by green tea extracts: case report and review of the literature M Molinari, KDS Watt, T Kruszyna, R Nelson, M Walsh, WY Huang, ... Liver transplantation 12 (12), 1892-1895, 2006 | 197 | 2006 |
| Orthotopic liver transplantation using low‐dose tacrolimus and sirolimus VC McAlister, KM Peltekian, DA Malatjalian, S Colohan, S MacDonald, ... Liver transplantation 7 (8), 701-708, 2001 | 185 | 2001 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The Lancet Gastroenterology & Hepatology 7 (5), 388-390, 2022 | 164 | 2022 |
| Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience P Ghali, PJ Marotta, EM Yoshida, VG Bain, D Marleau, K Peltekian, ... Liver transplantation 11 (11), 1412-1416, 2005 | 163 | 2005 |
| Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low‐dose tacrolimus regimen vs. a standard … EM Yoshida, PJ Marotta, PD Greig, NM Kneteman, D Marleau, ... Liver transplantation 11 (9), 1064-1072, 2005 | 161 | 2005 |
| Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. JW Ding, Q Ning, MF Liu, A Lai, J Leibowitz, KM Peltekian, EH Cole, ... Journal of virology 71 (12), 9223-9230, 1997 | 149 | 1997 |
| Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. KM Peltekian, F Wong, PP Liu, AG Logan, M Sherman, LM Blendis American Journal of Gastroenterology (Springer Nature) 92 (3), 1997 | 125 | 1997 |
| Rifaximin vs conventional oral therapy for hepatic encephalopathy: a meta-analysis KM Eltawil, M Laryea, K Peltekian, M Molinari World journal of gastroenterology: WJG 18 (8), 767, 2012 | 121 | 2012 |
